Vol 39 No. 2 Index PDF

Subject Index to Volume 39

Symbols
5-fluorouracil, 84

A
Ab interno trabeculotomy, 98
AcrySof toric, 70
Age-related macular degeneration, 62
Amblyopia, 57
Ankle/brachial index, 12, 13, 14
Anterior segment time-domain
optical coherence tomography, 95
Appositional closure, 94
Aqueous tear deficiency, 6, 7
Astigmatic keratotomy, 68
Astigmatic keratotomy, 71
Astigmatism, 67
Atrophic pterygium, 74
Autofluorescence measurement, 64
Autofluorescence spectrometry, 64

B
Baseline Macular Pigment Optical Density, 64
Best-corrected visual acuity, 71, 79
Best corrected distance visual
acuity (BCDVA), 67
Beta-irradiation, 74
Bevacizumab, 78, 84, 87
Birmingham Eye Trauma Terminology, 28
Bupivacaine HCl, 74

C
C-loop designs, 68
Carl Zeiss Meditec’s Visucam 500, 65
Cefuroxime, 34
Central foveal thickness, 79, 80
Central serous retinopathy, 17
Cevimeline, 7
Cholinergic agonists, 7
Conjunctival autograft, 73, 76
Corneal astigmatism, 69
Corneal blindness, 22
Corneal scarring, 74
Cultured human Tenon’s capsule fibroblasts, 84
Cyclotorsion of the eye, 72
Cylinder reduction, 67
Cylindrical correction, 68
Cystoid macular edema, 79

D
Delphi technique, 58
Depression, 19
Diabetes mellitus, 12
Diabetic macular edema, 78, 92
Diabetic retinopathy, 12
Diabetic retinopathy, 79, 90
Diabetic retinopathy screening, 90
Dilated retinal examination, 91
Double C-loop design, 69
Dry Eye, 6
Dry eye syndrome, 7

E
Endophthalmitis, 33, 34
Envista toric, 70
Epiretinal membrane, 79
Evaporative dry eye, 7
Excimer lasers (LASIK), 68
Eyecam, 95

F
Femtosecond laser technology, 68
Fibroblast cell viability, 87
Fibroblast growth factor, 87
FineVision toric, 70
FineVision toric lens, 71
Fleshy pterygium, 74
Fundus autofluorescence, 65

G
Glaucoma, 21, 22, 45, 46, 94
Glaucoma, 40
Glaucoma drainage device, 21
Glaucoma drug delivery system, 97
Glaucoma eye drops, 96
Gonioscopy, 94
Goniosynechialysis, 95

H
Harada’s disease, 17
Human Tenon’s fibroblasts, 84
Humphrey Visual Field Analyzer, 47
Humphrey Visual Field Index, 46
Hyperopic compound astigmatism, 68
Hypochondriasis, 19
Hysteria, 19

I
Intermediate pterygium, 74
Intracameral moxifloxacin, 33
Intraocular lens, 67
Intraocular pressure, 96
Intraocular pressure (IOP), 98
Intraoperative aberrometry, 72
Intravitreal bevacizumab, 80
Intravitreal injection, 78
Iridoplasty, 95
Iridotrabecular contact, 95
iStent, 98
iStent Supra, 98

J
Jenkins Activity Survey, 20

L
Laser iridectomy, 95
LEA chart, 59
LEA Numbers, 58, 60
LEA Symbols, 57, 59
Lidocaine HCl, 74
Limbal relaxing incision, 71
Lutein, 65

M
Macular pigment levels, 63
Macular pigment optical density, 62
Manifest refraction, 67
Microalbuminuria, 12, 15
Minimally Invasive Glaucoma Surgery, 98
Minnesota Multiphasic Personality
Inventory, 16, 17
Mitomycin-C, 21, 73, 84, 87
Monofocal toric model, 71
Moxifloxacin, 34, 36
Multifocal toric models, 71
Myopia, 39, 40, 43
Myopic globe elongation, 44

N
Neovascular AMD, 63, 65
Non-neovascular AMD, 63, 65
Nonproliferative diabetic retinopathy, 92

O
Obstruction of the visual axis, 74
Ocular Surface Disease Index, 6, 8
Ocular telemedicine, 91
Ocular Trauma Score, 27, 28
Open-angle glaucoma, 98
Optical coherence tomography, 39, 45
Optical coherence tomography, 79
Optic nerve head rim area, 47

P
Pediatric ocular trauma, 27
Penetrating keratoplasty, 21
Peripheral anterior synechiae involvement, 95
Peripheral arterial disease, 12
Phacoemulsification, 33, 35
Phacoemulsification, 70
Phenylephrine, 69
Philippine Eye Research Institute, 54
Pilocarpine, 6, 7, 10
Plate haptic designs, 68
Plating of fibroblast cells, 85
Preschool Vision Screening, 58
Proliferative diabetic retinopathy, 92
Prostaglandin, 96
Pseudophakic bullous keratopathy, 23
Pterygium, 73
Pterygium recurrence, 74

R
Recurrent pterygium, 73
Reflectance maps, 65
Refractive error, 44
Refractive outcomes, 67
Resazurin fluorimetric assays, 86
Retinal imaging, 91
Retinal nerve fiber layer, 39, 40
Retinal nerve fiber layer, 45
Retinal nerve fiber layer thickness, 43
Retinopathy Severity, 92
Retrobulbar anesthesia, 74

S
Sjogren’s syndrome, 7
Spectral-domain optical coherence tomography, 95
Spectral-domain optical coherence tomography, 46
Spherical refractive errors, 68
Standard automated perimetry, 46
Steroid-induced intraocular pressure elevation, 77
Strabismus, 57
Subretinal fluid, 79
Swept-source optical coherence tomography, 95

T
Teleophthalmology, 90
Tenon’s cyst, 76
Thiotepa application, 74
Tissue explants, 85
Tobramycin-dexamethasone, 75
Topographic astigmatism, 68
Toric Intraocular Lens, 67
Trabecular microbypass stent, 98
Trabeculectomy, 85
Trabeculectomy, 21
Triamcinolone acetonide, 84
Tropicamide, 69
Tukey test, 64

U
Ultrasound biomicroscope, 95
Uncorrected distance visual acuity (UDVA), 67
Uncorrected visual acuity, 71

V
Vancomycin, 34
Vascular endothelial growth factor, 87
Vascular endothelial growth factor (VEGF), 79
Visante, 95
Vision screening kit, 57
Vision Screening Recommendations, 58
Visual field index, 45, 47

Z
Zeaxanthin, 65
Zeiss and Oculentis lenses, 72
Zeiss Visucam 500, 64